Science topics: MedicineGynecology
Science topic

Gynecology - Science topic

Explore the latest questions and answers in Gynecology, and find Gynecology experts.
Questions related to Gynecology
  • asked a question related to Gynecology
Question
1 answer
How to change my primary affiliation in profile?
I can't change while editing profile.
I need change "St Petersburg University" to "D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg"
Relevant answer
Answer
I find it. Sorry.
  • asked a question related to Gynecology
Question
14 answers
Hello colleagues, I am a recent medical graduate with a strong interest in Obstetrics and Gynecology, actively looking for a research position in this field. I am particularly interested in projects related to reproductive health, maternal outcomes, gynecologic oncology, and health disparities. I am open to both paid and unpaid opportunities and highly motivated to contribute to advancing research in ObGyn. If you have or know of any available positions, I would love to connect.
Thank you for your support!
Answer this question
Relevant answer
Answer
Ohh.I just sent the message to the correct email address. I'm so sorry. The mistake was from my end🤦🏽‍♀️.
Thank you so much!
  • asked a question related to Gynecology
Question
2 answers
Hello colleagues, I am a recent medical graduate with a strong interest in Obstetrics and Gynecology, actively looking for a research position in this field. I am particularly interested in projects related to reproductive health, maternal outcomes, gynecologic oncology, and health disparities. I am open to both paid and unpaid opportunities and highly motivated to contribute to advancing research in ObGyn. If you have or know of any available positions, I would love to connect.
Thank you for your support!
Relevant answer
Answer
Currently, I am working as an independent researcher, focusing on topics related to obstetrics and gynecology. I am based in Monterrey, Mexico, but I am fully open to relocating for opportunities that align with my career goals and interests.
You can find more about my professional background on my LinkedIn profile: www.linkedin.com/in/karen-yunuén-diego-cruz-92825b28a
Feel free to contact me at my email: karendiegoc@gmail.com
Thank you for your consideration!
  • asked a question related to Gynecology
Question
9 answers
Two case reports (Marketkar et al., 2016 and Akkalp et al., 2015) share the same writing format and appear to have the same literature review. One might argue that because the cancer described is extremely rare, a literature search would result in the same set of articles. However, having an identical table without citing the source raises concerns.
If you see other similarities or have thoughts, please share.
References:
Marketkar, S.P., Hossain, T., Lawrence, W.D., and Quddus, M.R., 2016. Primary Signet-ring Cell Carcinoma of the Uterine Corpus: A Case Report and Review of the Literature. American Journal of Medical Case Reports, 4(2), pp.51-54.
Akkalp, A.K., Ozyurek, E.S., Tetikkurt, U.S., Yalcin, S., Koy, Y., and Usta, A.T., 2015. Primary Endometrial Adenocarcinoma with Signet‐Ring Cells: A Rarely Observed Case and Review of the Literature. Case Reports in Obstetrics and Gynecology, 2015(1), p.404692.
Relevant answer
Answer
might not be case of plagiarism because similar rare case may be reported by person in different journal not in same journal but Patients characteristic will be different for each case report
  • asked a question related to Gynecology
Question
2 answers
Dear Colleagues,
Today, the multidisciplinary management of patients with gynecological cancers represents a continuous challenge. This is mainly due to the two main outcomes for this subset of patients: survival, related to adequate and radical treatment, and quality of life, linked to the chance to be submitted to minimally invasive surgery that aims to preserve the reproductive and hormonal functionality of young patients and reduce postoperative morbidity.
The aim of this Special Issue is to provide a comprehensive overview of the advances in the diagnosis, prognostic stratification, and treatment of gynecologic oncologic patients.
Researchers in the field of gynecologic oncology, surgical oncology, and reproductive medicine are encouraged to submit their findings as original articles or reviews to this Special Issue.
Dr. Federica Perelli Dr. Marco D'Indinosante Guest Editors
Relevant answer
Answer
Thank you very much for your reply. We look forward to receiving your paper!
  • asked a question related to Gynecology
Question
1 answer
Relevant answer
Answer
As a (retired) paediatric radiologist I don't have large experience in paediatric gynaecology.
What I can say about neonates is this. To study the anatomy you may need contrast application via urethra or vagina. Be aware of the fact that the vagina in neonates is relatively large. The portio can be seen bulging inwards the vaginal wall. You can see the introitus to the uterus as well.
  • asked a question related to Gynecology
Question
3 answers
the branch of physiology and medicine which deals with the functions and diseases specific to women and girls, especially those affecting the reproductive system.
Relevant answer
Answer
The importance is a very big issue! I think it is because gynaecology covers such a wide area, relates to about half the population and deals with issues not experienced by the other 50% of the population!
Hence, there are many journals in this topic. Some examples are given here:
  • asked a question related to Gynecology
Question
3 answers
Who can help me and my 3 colleagues to visit gynecological department of hospitals in Istanbul from 19 till 24 of May. Thanks for any answer. 380677647766
Relevant answer
Answer
Hello. Thank You for answer!! I didn't find, but had a great time!!!. Hope to realize visiting of hospitals next time in Istanbul!!
  • asked a question related to Gynecology
Question
7 answers
Dear colleagues,
Do you have any knowledge about Juniper Publishers? Have any of you published in the Journal of Gynecology and Women's Health ( ISSN: 2474-7602, Impact Factor: 0.621 (2017-18))?
I found some information that the publisher may be predatory, but I do not have any certain opinion; however I have difficulties with finding the impact factor of the journal.
Here is the link to the official website of the journal: https://juniperpublishers.com/jgwh/
What do you think about publishing in the mentioned Journal?
I would be very grateful for any responses.
Best regards
Relevant answer
Answer
Indeed, the publisher “Juniper Publishers” behind the journal is mentioned in the list of potential predatory publishers: https://beallslist.net/ and by definition (at least according to Jeffrey Beall) all their journals need to be considered as such. So, a red flag for sure but not always enough for a final ‘judgement’. However, there are more red flags:
-Prominently mentioning impact factor is misleading. It mentions 2017-18 so even if this is true it basically said, ‘we used to have an impact factor’. Indeed, this journal cannot be found in the Clarivate Master journal list: https://mjl.clarivate.com/home so no real impact factor (you can check for journals with an impact factor in the enclosed file as well).
-Most likely the impact factor is fake and is mentioned here: https://isindexing.com/isi/journaldetails.php?id=7781 ISI indexing is a notorious example of a so-called misleading metric.
-Be aware that there are many so-called misleading metrics such as CiteFactor and DRJI: https://beallslist.net/misleading-metrics/
-Mentioning “PubMed indexed articles” is misleading. Since it suggests a real indexing of the journal while PubMed automatically index individual papers of researchers with a grant independently on whether a journal is PubMed indexed or not.
-Meaningless mentioning of for example ORCID and Sci-Hub which has nothing to do with quality of a journal and are not meant to be as such.
So definitely predatory and better to stay away from
Best regards.
  • asked a question related to Gynecology
Question
7 answers
Following, a link for answering to some questions on Intraepathic Cholestasis of Pregnancy
The survey is organized by th Clinical & Experimental Obstetrics and Gynecology Journal and results will be published on that journal (open).
I thank in advace people who will answer
Dr Ugo Indraccolo, M.D., Ph.D.
Relevant answer
Answer
Waiting for recommendations and guidelines. Involve neonatologists too.
  • asked a question related to Gynecology
Question
1 answer
Like to change some area of interest. Would like all gynecology areas included and if I still have space I will add obstetrics
Relevant answer
Answer
This function is to ask other researchers, not contact researchgate. You can use the contact page to reach them.
  • asked a question related to Gynecology
Question
3 answers
If anybody could advise from medical or chemical prospector
Relevant answer
Answer
I agree that sodium lactate and potassium lactate should more or less same properties. However, feeding extra potassium (depending on the amount) to the body might have more unexpected side-effects than feeding sodium, because -to my knowledge- there is 30-40times more sodium in blood than potassium.
  • asked a question related to Gynecology
Question
2 answers
I am looking for data sets containing real-world data for gynecology field. I would be grateful for suggestions of where I might find such data sets.
Relevant answer
Answer
May be the Cochrane Library?
  • asked a question related to Gynecology
Question
26 answers
As per rule/law, at least in India, we have to perform female sterilization with Pomeroys technique. But over the years, I came across several cases, where I feel this technique should not be used in some cases. For example
Previous 3/4 cesarean section
Previous rupture uterus and scar dehiscence this time
Scar dehiscence without labour in previous one scar
If we perform pomeroy's technque in these cases, there is a little chance of spontaneous recanalization, and surgical recanalization is never intended or advised in such cases.
Relevant answer
Answer
With the knowledge that most ovarian cancers originate from the fallopian tube (mostly the fimbria), I suspect that the standard for sterilisation may indeed change from segmental resection of the isthmus to fimbriectomy or salpingectomy in the future.
  • asked a question related to Gynecology
Question
1 answer
I have a patient, who is 43 years old, and has ovarian cyst discovered accidently by ultrasound (it looks simple apart from thin septa), her mother died because of epithelial ovarian cancer at about 65 years old, but nothing is known about the gene study of tumour, also the genetic predisposition of the patient is not known.
Relevant answer
Answer
I suggest doing BSO.
  • asked a question related to Gynecology
Question
2 answers
Has someone experienced analogous cases? Were these cases successful?
Relevant answer
Answer
This report is about use of aromatase inhibitors. ICSI - for what? What is ROS?
  • asked a question related to Gynecology
Question
8 answers
National or international practice guideline?
Relevant answer
Answer
But also I would suggest following references worth mentioning with an insight on cardiovascular system:
1. Bello N. Epidemiology of coronary heart disease in women / N. Bello, L. Mosca // Prog Cardiovasc Dis. – 2004. – Vol. 46. – Р.287-295.
2. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial / Anderson G.L., Limacher M., Assaf A.R. [et al.] // JAMA. – 2004. – Vol. 291. – P.1701-1712.
3. Elevated arterial stiffness in postmenopausal women with osteoporosis / H. Sumino, S. Ichikawa, S. Kasama [et al.] // Maturitas. – 2006. – Vol. 55. – Р. 212–218.
4. Eric Levens. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT) — The University of Florida experience / Levens Eric, R. Stan Williams // American Journal of Obstetrics and Gynecology. – 2004. – Vol. 191, № 2. – Р. 641-646.
5. Estrogen plus progestin and the risk of coronary heart disease / Manson J.E., Hsia J., Johnson K.C. [et al.] // N Engl J Med. – 2003. – Vol. 349. – P. 523-534.
6. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update / L. Mosca [et аl.] // Circulation. – 2007. – Vol. 115. – Р. 1481-1501.
7. Evidence-based guidelines for cardiovascular disease prevention in women / Mosca L., Appel L.J., Benjamin E.J. [et al.] // Circulation. – 2004. – Vol. 109. – P. 672-693.
8. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases / N. Jochmann, K. Stangl, E. Garbe [et al.] // Eur Heart J. – 2005. – Vol. 26, №16. – P. 1585-1595.
9. Gender differences in recovery after coronary artery bypass surgery / Vaccarino V., Lin Z.Q., Kasl S.V. [et al.] // J Am Coll Cardiol. – 2003. Vol. 41 – P. 307-314.
10. Gender-related effects on metoprolol pharmacokinetics and pharmaco-dynamics in healthy volunteers / A.B. Luzier, A. Killian, J.H. Wilton, M.F. Wilson // Clin Pharmacol Ther. – 1999. – Vol. 66. – P. 594-601.
11. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association / Mosca L., Collins P., Herrington D.M. [et al.] // Circulation. – 2001. – Vol. 104. – P. 499–503.
12. Hyperhomocysteinemia in menopausal hypertension: an added risk factor and a dangerous association for organ damage / R. Noto, S. Neri, G. Molino [et al.] // Eur Rev Med Pharmacol Sci. – 2002. – Vol. 6, №4 – P. 81-88.
13. Igweh J.C. The effects of menopause on the serum lipid profile of normal females of South East Nigeria / J.C. Igweh, I.U. Nwagha, J.M. Okaro // Niger J Physiol Sci. – 2005. – Vol. 20, №1. – Р. 48-53.
14. Jacobs A.K. Coronary revascularization in women 2003. Sex revisited / A.K. Jacobs // Circulation. – 2003. – Vol.107. – P. 375-377.
15. Kannel W.B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study / W.B. Kannel // Am Heart J. – 1987. – Vol. 114, №2. – Р. 413-422.
16. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial / L.H. Kuller, L.S. Kinzel, K.K. Pettee [et al.] // J Womens Health. – 2006. – Vol. 15, №8. – Р. 962-974.
17. Luboshitzky R. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism / R. Luboshitzky, P. Herer // Neuro Endocrinol Lett. – 2004. – Vol. 25, №4. – Р. 262-268.
18. Montalcini T. Endogenous testosterone and endothelial function in postmenopausal women / T. Montalcini, G. Gorgone, C. Gazzaruso // Coron Artery Dis. – 2007. – Vol. 18, №1. – Р. 9-13.
19. Nielsen N. E. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics / N. E. Nielsen, A. G. Olsson, E. Swahn // Journal of Internal Medicine. – 2000. – Vol. 247. – Р. 43-52.
20. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial / Rossouw J.E., Anderson G.L., Prentice R.L. [et al.] // JAMA. – 2002. – Vol. 288. – P. 321–333.
21. Rosano G.M. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system / G.M. Rosano, C. Vitale, M. Fini // Ann N Y Acad Sci. – 2006. – Vol. 1092. – Р. 341-348.
22. Rossouw J.E. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease / J.E. Rossouw // Ann N Y Acad Sci. – 2006. – Vol. 1089. – Р. 444-453.
23. Serum sex hormones in premenopausal women with coronary heart disease / M.J. Mohamad, M.Karayyem, M.A.Mohammad [et al.] // Neuro Endocrinol Lett. – 2006. – Vol. 27, №6. – Р. 758-762.
24. Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease / Carl J. Pepine, Richard A. Kerensky, Charles R. Lambert [et al.] // Journal of the American College of Cardiology. – 2006. – Vol. 47, №3. – Р. 30-35.
25. The Women’s Health Initiative Steering Committee. Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial // JAMA. – 2004. – Vol. 291. – Р. 1701-1712.
26. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation / D’Agostino R.B.Sr, Grundy S., Sullivan L.M. [et al.] // JAMA. – 2001.- Vol. 286. - P. 180–187.
27. Wenger N.K. Coronary heart disease: The female heart is vulnerable / N.K. Wenger // Prog Cardiovasc Dis. – 2003. – Vol. 46. – P. 199-229.
28. Wenger N.K. Menopausal hormone therapy and cardiovascular disease / N.K. Wenger // Rev Esp Cardiol. – 2006. – Vol. 59, №10. – P. 1058-1069.
  • asked a question related to Gynecology
Question
13 answers
There is the notion that a MUS is sometimes sufficient for treating anterior POP.
Relevant answer
Answer
MUS reinforces a lax pubourethral ligament (PUL), the prinicipal cause of USI. PUL is not a cause of cystocele. Cystocele is caused by laxity in either by dislocation of the cardinal ligament (CL) &pubocervical fascia (PCF) attachments to the anterior cervical ring and/or dislocation of PCF to ATFP, or TAFP from its insertion into the ischial spine.
If the 15 minute anterior repair involves excision of vaginal tissue, all it will do is shorten the vagina and cause further prolapse.
A vaginal repair with conservation of vaginal tissue is far more preferable.
The problem with mesh sheets such as Elevate is that they are placed into the vesicovaginal space. This glues the vagina to the bladder and eliminates the vesicovaginal space which is importan for normal movement by the pelvic floor muscles. Excess tension by Perigee is a major cause of pelvic pain. Such meshes are difficult to remove surgically.
Bottom line: if the POP is low grade , leave it alone.
  • asked a question related to Gynecology
Question
3 answers
I have relative she is 34 years old and suffering from fibroadenoma, it keeps on coming and going, what is your opinion?
Relevant answer
Answer
Only proceed to the removal of fibroadenoma:
- By request of the patient (usually cancerophobia)
- Faced with uncertain diagnosis
- For tumor size that causes breast deformity
- By rapid growth
- If pain occurs
  • asked a question related to Gynecology
Question
4 answers
There is increasing body of evidence that less-invasive or non-invasive procedures like uterine artery embolization and MR-guided High Focus Ultrasound treatments are effective for the treatment of uterine fibroids. In addition hysterectomies and myomectomies are associated with morbidity, mortality and significant costs to society. Although some studies demonstrate a gradual decrease in surgical invasive procedures for uterine fibroids adoption of newer non-invasive alternatives iby gynecologists is slow.
Relevant answer
Answer
La UAE It can be considered an alternative to multiple myomectomy, especially in women and operated or considered high risk (large number of fibroids, anemia, history of previous abdominal surgery, ..)
Two. Also propose embolization in women who reject any surgical intervention.
Three. Can also be used in surgery so preoperative programmed multiple fibroids and / or bulky and therefore allows less haemorrhagic surgery and subsequent reduction in tumor volume before multiple myomectomy. It can be further combined with hysteroscopic resection of submucous myomas some.
4.Can be an alternative to hysterectomy in patients with multiple fibroids symptomatic perimenopausal, and
5. No indication has been established her as a unique alternative to myomectomy in patients with infertility.
MRgFUS:
Exclusion criteria
- Pregnant / lactating
- History of previous embolization
- Extensive abdominal scar
- Abdominal Tattoos
- History of liposuction
- Weight> 110 kg or BMI> 30 kg/m2
- Claustrophobia or inability to communicate
- Contraindication to prolonged posture
- Uterus> 26 weeks or with a volume> 300cc
-> 3 fibroids> 4 cm
- Mioma> 12 cm
- Pedunculated subserous myoma
- Myoma calcified
- Intracavitary myoma> 3 cm
- Serious medical illness: IR, ACVA, unstable heart disease, anticoagulation
etc.
  • asked a question related to Gynecology
Question
10 answers
I have a 25 year old patient who underwent a Cesarean Section 3 weeks ago. Ever since the C-Section, she has been complaining of generalized abdominal pain and cough. Her ultrasound abdomen showed gross ascites. An ascitic tap was done and the fluid showed predominant lymphocytes. She was given some diuretics after which her ultrasound abdomen shows only minimal ascites. However she now has diarrhea. She still has generalized abdominal pain and cough. Her investigations showed mildly raised ESR and mildly raised ALT. Her mantoux, mycodot and chest x ray are clear. There was no indication of a sponge left in the abdomen on the ultrasound. Her abdomen is tender however there is no palpable mass. Her fever is 99-100 degrees Fahrenheit. Does anyone have any suggestions on how to proceed? Thank you for your help, in advance.
Relevant answer
Answer
She's postpartum patient. What about pelvic organs?
  • asked a question related to Gynecology
Question
2 answers
I am looking to write an article about maternal depression and would like some stats on depression beyond PND.
Relevant answer
Answer
Thank you! Glad to see someone finally answered :-)